Skip to main content

Five of the nation’s leading comprehensive cancer centers have joined forces as the UC Cancer Consortium (UCCC) to bring together the expertise of physicians, health professionals, researchers, data scientists and other UC partners on systemwide projects to fight cancer and optimize care.

UCCC initiatives include a joint effort to combine cancer data from all five cancer centers and make it readily available across the UC to revolutionize evidence-based care for UC patients; projects to improve the quality of cancer care; and multi-campus collaborations that address disease- and audience-specific challenges. The UCCC also serves California communities by advocating for cancer-related policies that advance health equity.

The UCCC is led by the directors of the five UC NCI-Designated Comprehensive Cancer Centers. The directors share leadership responsibility by rotating the chair and co-chair roles.

Data and precision oncology

Data-driven precision medicine is increasingly important for delivering the best personalized cancer treatment. The UCCC aims to leverage UC data to foster innovative research and improve cancer patient outcomes. The UCCC is working on enhancing the UC Health Data Warehouse to include de-identified data—such as cancer genomics—to make cancer patient data accessible to UC researchers and scientists.

Improving quality of care

The UCCC brings together providers and health professionals through the UCCC Quality Council to share best practices and collaborate on projects to make evidence-based improvements in care for all UC cancer patients. Current projects include a collaboration with UC Population Health on the UC Way Oncology Medical Home Initiative.

UCCC Molecular Tumor Board

Cancer is not one disease but many diseases, driven by case-specific factors including patient and tumor genomics. The UCCC Molecular Tumor Board provides UC clinicians, scientists and researchers a forum to discuss the best options for individual patients based on the genomic alterations present in their cancer.

Learn more

Systemwide consortia and collaborations

Teams focused on tumor types, patient populations, and other interest areas collaborate to leverage expertise from throughout the UC system and advance clinical care and research.

UC Lung Cancer Consortium

UC Melanoma and Skin Cancer Consortium

UC Molecular Oncology Data and Experimental Research Network (UC-MODERN)

UC Pancreatic Cancer Consortium

Upcoming events

Pancreatic Cancer October Seminar Series
October 3, 2023, 8 a.m. PT
Speaker: Daniel Billadeau, Ph.D., Mayo Clinic
Title: The Multiple Roles of GSK-3beta in Pancreatic Cancer: From Development to Chemoresistance
Join the meeting.

Eighth Annual UC Heme Malignancies Consortium Research Symposium
October 12-13, 2023
Location: UC San Diego, Green Acre Campus Point
Register here (CME credit available for attendance on October 13).

Lung Cancer Consortium Quarterly Young Investigators/Journal Club
October 17, 5:30 p.m. PT
Speakers: Ashley Prosper, M.D., UCLA; David Tom Cooke, M.D., F.A.C.S., UC Davis; Amy L. Cummings, M.D., UCLA
For more information, contact Pauline McAlpin.

Pancreatic Cancer November Seminar Series
November 2, 2023, 8 a.m. PT
Speaker: Jason Link, Ph.D., UCLA
Title: Escape from Long-Term Tumor Immunity in Pancreatic Ductal Adenocarcinoma
Join the meeting.

Pancreatic Cancer November Seminar Series
December 5, 2023, 8 a.m. PT
Speaker: Rushika Perera, Ph.D., UCSF
Title: TBD
Join the meeting.

UC Pancreatic Cancer Consortium Symposium
Post-Pandemic Progress in Pancreatic Cancer Research
December 15, 2023
Location: UC Irvine
Registration and full details available here.

Subscribe to our newsletter

Receive updates from across the UCCC and its groups throughout the year.


* indicates required